Guobing Li
Overview
Explore the profile of Guobing Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Z, Wang F, Zaman M, Zhu B, Qin Y, Shen Q, et al.
J Colloid Interface Sci
. 2024 Aug;
677(Pt A):895-908.
PMID: 39126808
5-methyl-2-hexanone is used as a versatile polymerization solvent for industrial preparation processes of bulk and fine chemicals. An efficient catalyst, Pd/γ-AlO, is reported for the preparation of 5-methyl-2-hexanone by selective...
2.
Liu W, Zhou H, Lai W, Hu C, Wang Q, Yuan C, et al.
Cell Commun Signal
. 2024 Jul;
22(1):378.
PMID: 39061097
Artesunate (ART), a natural product isolated from traditional Chinese plant Artemisia annua, has not been extensively explored for its anti-melanoma properties. In our study, we found that ART inhibited melanoma...
3.
Wang F, Lai W, Xie D, Zhou M, Wang J, Xu R, et al.
J Adv Res
. 2024 Jun;
PMID: 38897272
Introduction: Chemoimmunotherapy, which benefits from the combination of chemotherapy and immunotherapy, has emerged as a promising strategy in cancer treatment. However, effectively inducing a robust immune response remains challenging due...
4.
Liu W, Zhou H, Lai W, Hu C, Xu R, Gu P, et al.
Immunol Res
. 2024 May;
72(4):566-582.
PMID: 38691319
Recent advances in cancer immunotherapy, especially immune checkpoint inhibitors (ICIs), have revolutionized the clinical outcome of many cancer patients. Despite the fact that impressive progress has been made in recent...
5.
Guo J, Xu R, Liu R, Lai W, Hu C, He H, et al.
J Transl Med
. 2024 Jan;
22(1):96.
PMID: 38263194
Background: Periodontitis is a chronic oral inflammatory disease that seriously affects people's quality of life. The purpose of our study was to investigate the correlation between the systemic immune inflammation...
6.
Wang Q, Liu W, Zhou H, Lai W, Hu C, Dai Y, et al.
Neoplasia
. 2024 Jan;
48:100966.
PMID: 38237304
Although immune checkpoint therapy has significantly improved the prognosis of patients with melanoma, urgent attention still needs to be paid to the low patient response rates and the challenges of...
7.
Dai Y, Hu C, Zhou H, Liu W, Lai W, Xu R, et al.
FEBS J
. 2023 Aug;
290(24):5720-5743.
PMID: 37581853
Src homolog and collagen homolog binding protein 1 (SHCBP1) binds to the SH2 domain of SHC-transforming protein 1 (SHC1) and is involved in midbody organization and cytokinesis completion. SHCBP1 has...
8.
Zhou M, Liao J, Lai W, Xu R, Liu W, Xie D, et al.
EBioMedicine
. 2023 Jul;
94:104724.
PMID: 37480625
Background: Cancer is the world's leading cause of death and a key hindrance to extending life expectancy. Celastrol, a bioactive compound derived from Tripterygium wilfordii, has been shown to have...
9.
Liu Y, Liu W, Li G, Lai W, Hu C, Zhang Q, et al.
Biomed Mater
. 2023 Mar;
18(3).
PMID: 36917859
CuSe nanoparticles (CuSe NPs) as a new therapeutic drug platform is widely used in disease treatment due to their strong near-infrared optical absorption. In recent years, with their continuous expansion...
10.
Zhou M, Liao J, Li G, Yu Z, Xie D, Zhou H, et al.
Carbohydr Polym
. 2022 Jul;
294:119805.
PMID: 35868765
Uncontrolled hemorrhage poses a severe life-threatening situation. However, traditional hemostats still have various limitations. It is urgent to develop a material with excellent biocompatibility and hemostatic ability. Evidence has shown...